369 related articles for article (PubMed ID: 33570949)
1. Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases.
Ben-Shushan S; Miller Y
J Phys Chem B; 2021 Mar; 125(11):2796-2811. PubMed ID: 33570949
[TBL] [Abstract][Full Text] [Related]
2. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
3. Rebalancing metal dyshomeostasis for Alzheimer's disease therapy.
Yang GJ; Liu H; Ma DL; Leung CH
J Biol Inorg Chem; 2019 Dec; 24(8):1159-1170. PubMed ID: 31486954
[TBL] [Abstract][Full Text] [Related]
4. Management of oxidative stress and other pathologies in Alzheimer's disease.
Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
[TBL] [Abstract][Full Text] [Related]
5. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
Robert A; Liu Y; Nguyen M; Meunier B
Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
[TBL] [Abstract][Full Text] [Related]
6. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
7. Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ
Sun L; Sharma AK; Han BH; Mirica LM
ACS Chem Neurosci; 2020 Sep; 11(17):2741-2752. PubMed ID: 32786307
[TBL] [Abstract][Full Text] [Related]
8. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N; Lee HJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
[TBL] [Abstract][Full Text] [Related]
9. Potential molecular and graphene oxide chelators to dissolve amyloid-β plaques in Alzheimer's disease: a density functional theory study.
Liu C; Luo X
J Mater Chem B; 2021 Mar; 9(11):2736-2746. PubMed ID: 33688880
[TBL] [Abstract][Full Text] [Related]
10. Metallothioneins and synthetic metal chelators as potential therapeutic agents for removal of aberrant metal ions from metal-Aβ species.
Xia N; Liu L
Mini Rev Med Chem; 2014; 14(3):271-81. PubMed ID: 24456271
[TBL] [Abstract][Full Text] [Related]
11. Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease.
Chaudhari V; Bagwe-Parab S; Buttar HS; Gupta S; Vora A; Kaur G
Neurotox Res; 2023 Jun; 41(3):270-287. PubMed ID: 36705861
[TBL] [Abstract][Full Text] [Related]
12. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
Cherny RA; Legg JT; McLean CA; Fairlie DP; Huang X; Atwood CS; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Biol Chem; 1999 Aug; 274(33):23223-8. PubMed ID: 10438495
[TBL] [Abstract][Full Text] [Related]
13. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
[TBL] [Abstract][Full Text] [Related]
14. Metal ions, Alzheimer's disease and chelation therapy.
Budimir A
Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
[TBL] [Abstract][Full Text] [Related]
15. Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.
Zhong G; Wang X; Li J; Xie Z; Wu Q; Chen J; Wang Y; Chen Z; Cao X; Li T; Liu J; Wang Q
Curr Neuropharmacol; 2024; 22(10):1650-1671. PubMed ID: 38037913
[TBL] [Abstract][Full Text] [Related]
16. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.
Miller LM; Wang Q; Telivala TP; Smith RJ; Lanzirotti A; Miklossy J
J Struct Biol; 2006 Jul; 155(1):30-7. PubMed ID: 16325427
[TBL] [Abstract][Full Text] [Related]
17. Neurodegenerative diseases and therapeutic strategies using iron chelators.
Ward RJ; Dexter DT; Crichton RR
J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
[TBL] [Abstract][Full Text] [Related]
18. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
19. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
20. Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases.
Hague T; Andrews PL; Barker J; Naughton DP
Behav Pharmacol; 2006 Sep; 17(5-6):425-30. PubMed ID: 16940763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
